Table 1

Demographic, clinical characteristics and treatment outcome

Primary isolated distal occlusion (group 1)Secondary DMVO following MT of a proximal vessel occlusion (group 2)Distal thrombectomy during elective AVM or aneurysm embolization (group 3)
Patient characteristicsn=34n=71n=10
Age, mean (SD)76 (12)74 (15)46 (17)
Female sex, n (%)17 (50)41 (57.8)5 (50)
Prior IVT, n (%)23 (67.6)27 (38.0)NA
NIHSS at admission, median (range)7 (0–22)11 (0–31)NA
NIHSS at 24 hours, median (range)6 (0–31)8 (0–31)NA
NIHSS at discharge, median (range)3 (0–31)5 (0–23)NA
Successful recanalization (eTICI 2b67-3), n (%)24 (70.5)52 (73.2)10 (100)
No of passes with Tigertriever 13, median (range)2 (1–4)1 (1–5)1 (1–3)
Duration of MT procedure (min), mean (SD)71 (50.1)104 (68.2)NA
Contrast agent extravasation in CBCT immediately after thrombectomy, n (%)16 (47.0)31 (43.6)0
Asymptomatic intracranial bleeding,* n (%)7 (20.6)12 (16.9)0
Symptomatic intraparenchymal bleeding, n (%)3 (8.8)5 (7.0)0
In-hospital mortality, n (%)4 (11.8)15 (21.1)NA
  • *Including subarachnoid and intra-parenchymal.

  • AVM, arteriovenous malformation; CBCT, cone-beam CT; DMVO, distal medium vessel occlusion; eTICI, extended Thrombolysis in Cerebral Infarction; IVT, intravenous thrombolysis; MT, mechanical thrombectomy.